The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

7 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Modified norcantharidins; synthesis, protein phosphatases 1 and 2A inhibition, and anticancer activity.EBI
University of California Irvine
Cantharimides: a new class of modified cantharidin analogues inhibiting protein phosphatases 1 and 2A.EBI
The University of Newcastle
Anhydride modified cantharidin analogues: synthesis, inhibition of protein phosphatases 1 and 2A and anticancer activity.EBI
The University of Newcastle
Anti-inflammatory and anticancer p-terphenyl derivatives from fungi of the genus Thelephora.EBI
Oncowitan
Microcystin analogues comprised only of Adda and a single additional amino acid retain moderate activity as PP1/PP2A inhibitors.EBI
University of California Irvine
Inhibition of striatal-enriched protein tyrosine phosphatase by targeting computationally revealed cryptic pockets.EBI
Shandong University
Importance of the C28-C38 hydrophobic domain of okadaic acid for potent inhibition of protein serine-threonine phosphatases 1 and 2A.EBI
University of Minnesota